AQB
AquaBounty Technologies, Inc. NASDAQ Listed Jan 11, 2017$1.03
-3.74%
vs $1.07
Mkt Cap $4.0M
52w Low $0.70
14.7% of range
52w High $2.95
50d MA $0.98
200d MA $1.09
P/E (TTM)
—
EV/EBITDA
—
P/B
—
Debt/Equity
-1.8x
ROE
977.8%
P/FCF
-0.0x
RSI (14)
55.10
ATR (14)
$0.08
Beta
1.30
50d MA
$0.98
200d MA
$1.09
Avg Volume
43.4K
AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Maynard, Massachusetts.
2 Mill and Main Place · Maynard, MA 01754 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | AMC | -0.52 | -3.64 | -600.0% | 0.87 | +3.2% | +2.3% | -1.1% | +4.3% | -2.3% | +4.2% | — |
| Oct 28, 2025 | AMC | -0.62 | -0.36 | +41.9% | 1.46 | -0.7% | -9.6% | +0.8% | -2.3% | -6.2% | -13.1% | — |
| Aug 5, 2025 | AMC | -0.53 | -0.63 | -18.9% | 0.73 | -1.1% | -1.6% | +3.0% | +1.3% | +0.9% | -2.0% | — |
| May 15, 2025 | AMC | -0.61 | 0.16 | +126.2% | 0.77 | -3.0% | +2.0% | +4.9% | +0.6% | +8.8% | -5.6% | — |
| Mar 31, 2025 | AMC | -0.61 | -21.77 | -3469.6% | 0.69 | -5.6% | -3.5% | +3.8% | -4.0% | -3.3% | +2.0% | — |
| Nov 5, 2024 | AMC | -0.89 | -0.88 | +1.1% | 1.15 | -1.7% | -4.3% | +0.0% | -2.7% | -4.7% | +2.9% | — |
| Aug 6, 2024 | AMC | -0.93 | -1.56 | -67.7% | 1.39 | +5.0% | -3.6% | +3.7% | +2.2% | -6.3% | -3.0% | — |
| May 15, 2024 | AMC | -1.42 | -1.53 | -7.7% | 2.00 | -2.5% | -0.5% | -8.5% | +4.4% | +1.6% | -1.0% | — |
| Apr 1, 2024 | AMC | -1.52 | -2.19 | -44.1% | 2.02 | -2.0% | -1.5% | -0.5% | -2.5% | +1.0% | -1.5% | — |
| Nov 7, 2023 | AMC | -2.02 | -1.60 | +20.8% | 2.96 | -4.1% | -9.8% | -2.2% | -11.9% | -6.5% | -1.4% | — |
| Aug 1, 2023 | AMC | -1.60 | -1.80 | -12.5% | 7.00 | +0.3% | -8.3% | -3.1% | -8.7% | -8.8% | +10.0% | — |
| May 4, 2023 | AMC | -1.60 | -1.80 | -12.5% | 10.70 | +0.0% | +1.9% | -1.3% | -0.7% | -0.6% | +0.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 2 | Oppenheimer | Maintains | Perform → Perform | — | $2.02 | $1.98 | -2.0% | -1.5% | -0.5% | -2.5% | +1.0% | -1.5% |
| Nov 8 | HC Wainwright & Co. | Downgrade | Buy → Neutral | — | $2.96 | $2.84 | -4.1% | -9.8% | -2.2% | -11.9% | -6.5% | -1.4% |
| Oct 20 | Oppenheimer | Downgrade | Outperform → Perform | — | $3.69 | $3.60 | -2.4% | -8.4% | +1.5% | -9.0% | -12.5% | -6.2% |
| Aug 2 | Oppenheimer | Maintains | Outperform → Outperform | — | $7.00 | $7.02 | +0.3% | -8.3% | -3.1% | -8.7% | -8.8% | +10.0% |
| Aug 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.00 | $7.02 | +0.3% | -8.3% | -3.1% | -8.7% | -8.8% | +10.0% |
| Aug 1 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.74 | $8.00 | +3.4% | -9.6% | -8.3% | -3.1% | -8.7% | -8.8% |
| Aug 1 | Oppenheimer | Maintains | Outperform → Outperform | — | $7.74 | $8.00 | +3.4% | -9.6% | -8.3% | -3.1% | -8.7% | -8.8% |
| Jun 5 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.90 | $7.84 | -0.8% | -9.4% | +1.7% | -1.4% | +4.2% | -3.7% |
| Jun 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| May 5 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $10.70 | $10.70 | +0.0% | +1.9% | -1.3% | -0.7% | -0.6% | +0.0% |
| May 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $11.04 | $10.78 | -2.4% | -3.1% | +1.9% | -1.3% | -0.7% | -0.6% |
| Mar 8 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $13.26 | $14.00 | +5.6% | +3.5% | -4.8% | -4.3% | -1.6% | -7.2% |
| Nov 9 | HC Wainwright & Co. | Upgrade | Neutral → Buy | — | $77.20 | $77.90 | +0.9% | +0.5% | -3.1% | -0.8% | +0.5% | -2.7% |
| Nov 8 | HC Wainwright & Co. | Upgrade | Neutral → Buy | — | $74.60 | $74.68 | +0.1% | +3.5% | +0.5% | -3.1% | -0.8% | +0.5% |
| Oct 8 | Roth Capital | Maintains | Buy → Buy | — | $75.60 | $76.40 | +1.1% | +3.2% | -2.1% | +2.6% | +4.1% | -1.2% |
| Jul 1 | Oppenheimer | Maintains | Outperform → Outperform | — | $107.20 | $111.20 | +3.7% | +5.8% | -3.4% | -1.1% | -2.6% | -2.3% |
| Mar 10 | HC Wainwright & Co. | Downgrade | Buy → Neutral | — | $139.60 | $137.60 | -1.4% | -3.7% | +4.8% | +6.7% | +2.0% | -5.1% |
| Mar 9 | HC Wainwright & Co. | Downgrade | Buy → Neutral | — | $127.50 | $132.60 | +4.0% | +9.5% | -3.7% | +4.8% | +6.7% | +2.0% |
| Mar 26 | H.C. Wainwright | Maintains | Buy → Buy | — | $36.20 | $36.00 | -0.6% | +1.1% | +0.3% | -8.0% | -3.6% | +1.2% |
| Jan 13 | National Securities | Upgrade | Neutral → Buy | — | $47.72 | $50.80 | +6.5% | +3.1% | +8.1% | -9.4% | +0.8% | -7.6% |
| Jan 12 | National Securities Corporation | Upgrade | Neutral → Buy | — | — | — | — | — | — | — | — | — |
| Mar 6 | National Securities | Maintains | Buy → Buy | — | $42.20 | $42.60 | +0.9% | +4.3% | +1.8% | +118.3% | -26.2% | -3.6% |
| Jun 28 | H.C. Wainwright | Maintains | Buy → Buy | — | $60.80 | $61.60 | +1.3% | -2.6% | +12.5% | -3.9% | +0.6% | -1.6% |
No insider trades available.
8-K · 3.02
!! High
AquaBounty Technologies, Inc. -- 8-K 3.02: Unregistered Securities Offering
Jun 30
8-K
AquaBounty Technologies, Inc. -- 8-K Filing
Jun 25
8-K · 5.03
! Medium
AquaBounty Technologies, Inc. -- 8-K 5.03: Amendment to Articles / Bylaws
AquaBounty Technologies shifted its fiscal year-end, which may alter the timing of financial reporting and investor communications going forward.
Apr 17
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
AquaBounty's 8-K filing indicates a material announcement, though the specific details are technical; investors should monitor the next earnings report or press release for concrete business impact.
Apr 8
8-K · 1.01
!! High
Unknown — 8-K 1.01: Material Agreement
AQB entered a material agreement with Univest Securities likely for underwriting or financial advisory services, signaling preparation for capital raising that could dilute shareholders or fund growth initiatives.
Apr 8
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
The departure uncertainty surrounding board member Sterling has been resolved with his continued service, reducing potential governance disruption concerns that could have negatively impacted AQB's stock valuation and investor confidence.
Mar 31
8-K · 1.01
!! High
AquaBounty Technologies, Inc. -- 8-K 1.01: Material Agreement
AquaBounty Technologies entered a Securities Purchase Agreement with Univest Securities, potentially securing capital through a direct securities offering to fund operations or growth initiatives.
Feb 12
8-K · 5.02
!!! Very High
AquaBounty Technologies, Inc. -- 8-K 5.02: Executive Change
AquaBounty Technologies' executive change via amended 8-K filing indicates leadership restructuring, though the specific personnel transition details require reviewing the complete filing to assess impact on the genetically modified salmon company's operations and strategy.
Feb 4
Institutional (13F) — Top 0
All ↗
No 13F holders found.
Mutual Funds / ETFs (N-PORT) — Top 1
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | Guggenheim Active Allocation Fund | 17 | $16 | Feb 2026 |
Valuation
Market Cap
$4.0M
Enterprise Value
$7.0M
P/E (TTM)
—
Forward P/E
—
PEG Ratio
0.00x
P/B
—
P/S
—
P/FCF
-0.00x
EV/EBITDA
—
Shares Out
3.9M
Financials (TTM)
Revenue
$0
Net Income
-$20.1M
EBITDA
-$3.2M
Free Cash Flow
-$8.74B
Op Cash Flow
-$8.74B
EPS Basic
$-4.77
EPS Diluted
$-5.13
EPS Forward
$-7.28
Gross Margin
—
Op Margin
—
Net Margin
—
Balance Sheet
Total Assets
$10.3M
Total Liab.
$12.2M
Total Equity
-$1.9M
Cash
$501K
LT Debt
$3.5M
Book Value/Sh
$-0.49
Debt/Equity
-1.84x
Current Ratio
1.18
Quick Ratio
1.18
Returns & Growth
ROE
977.8%
ROA
-178.8%
ROIC
-251.9%
Rev Growth YoY
+0.0%
EPS Growth YoY
+87.7%
Price Returns
2W
+1.0%
1M
+3.0%
3M
+12.8%
6M
+8.4%
12M
+35.3%
Technicals
52W High
$2.95
52W Low
$0.70
50d MA
$0.98
200d MA
$1.09
RSI (14)
55.10
ATR (14)
$0.08
Beta
1.30
Avg Volume
43K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$3.00
High
$4.00
Low
$2.00
Median
$3.00
Data updated apr 24, 2026 6:39pm
· Source: financialmodelingprep.com